The Role of Willingness of Participation in Cardiology Trials on the Survival of Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03840499

Enrollment

400

Registered

2019-02-15

Start date

2018-10-01

Completion date

2022-12-31

Last updated

2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure, Myocardial Infarction

Brief summary

It has been shown retrospectively that participation and even the willingness improves the survival of patients after myocardial infarction or heart failure. We aimed to prospectively analyse the role of participation in cardiology trials on the survival of patients in a high volumen tertiary center.

Interventions

DRUGOptimal medical therapy

Optimal medical therapy

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Hospitalisation due to acute myocardial infarction, and or heart failure * Singed informed consent

Exclusion criteria

* Previous participation in any clinical study * Haemodinamically instable, shock, intubation * Pregnancy, breast feeding

Design outcomes

Primary

Measure	Time frame
All-cause mortality	2-years

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026